- Home
- CDNA vs NXRT Comparison
CDNA vs NXRT Comparison
Compare CDNA & NXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- NXRT
- Stock Information
- Founded
- CDNA 1998
- NXRT 2014
- Country
- CDNA United States
- NXRT United States
- Employees
- CDNA N/A
- NXRT N/A
- Industry
- CDNA Medical Specialities
- NXRT Real Estate Investment Trusts
- Sector
- CDNA Health Care
- NXRT Real Estate
- Exchange
- CDNA Nasdaq
- NXRT Nasdaq
- Market Cap
- CDNA 1.0B
- NXRT 874.3M
- IPO Year
- CDNA 2014
- NXRT N/A
- Fundamental
- Price
- CDNA $19.04
- NXRT $33.57
- Analyst Decision
- CDNA Buy
- NXRT Hold
- Analyst Count
- CDNA 6
- NXRT 6
- Target Price
- CDNA $30.33
- NXRT $41.88
- AVG Volume (30 Days)
- CDNA 996.2K
- NXRT 147.8K
- Earning Date
- CDNA 07-30-2025
- NXRT 07-29-2025
- Dividend Yield
- CDNA N/A
- NXRT 6.10%
- EPS Growth
- CDNA N/A
- NXRT N/A
- EPS
- CDNA 1.07
- NXRT N/A
- Revenue
- CDNA $346,421,000.00
- NXRT $255,529,000.00
- Revenue This Year
- CDNA $13.31
- NXRT N/A
- Revenue Next Year
- CDNA $15.46
- NXRT $5.35
- P/E Ratio
- CDNA $17.61
- NXRT N/A
- Revenue Growth
- CDNA 25.92
- NXRT N/A
- 52 Week Low
- CDNA $13.48
- NXRT $30.98
- 52 Week High
- CDNA $34.84
- NXRT $48.37
- Technical
- Relative Strength Index (RSI)
- CDNA 55.64
- NXRT 40.55
- Support Level
- CDNA $18.51
- NXRT $33.00
- Resistance Level
- CDNA $19.62
- NXRT $35.22
- Average True Range (ATR)
- CDNA 0.84
- NXRT 0.66
- MACD
- CDNA 0.02
- NXRT 0.02
- Stochastic Oscillator
- CDNA 66.12
- NXRT 30.90
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About NXRT NexPoint Residential Trust Inc.
NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.